连接性作为在非典型的阿尔茨海默病中tau进展的普遍预测因素
Hannah de Bruin1,2,3, Colin Groot1,2,4, Henryk Barthel5
1Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam 1081 HV, Netherlands.
Brain : a journal of neurology
|August 14, 2025
概括
阿尔茨海默病的病理在异型变体中沿大脑功能连接传播. 在后皮层缩和初级渐进性失语症中的这一发现可能会个性化治疗.
科学领域:
- 神经科学是一个神经科学.
- 神经病理学神经病理学
- 医疗成像医学成像
背景情况:
- 阿尔茨海默病 (AD) 的tau病理与临床症状有关,强调了变体之间的空间分布.
- 典型的AD tau进展遵循功能连接,但非典型的AD变体为连接的作用提供了独特的见解.
研究的目的:
- 为了调查大脑功能连接性支架是否在非典型的阿尔茨海默氏症变体中发生tau进展.
- 分析后皮层缩 (PCA-AD) 中的tau分布模式,logoopenic变体初级渐进性失言症 (lvPPA-AD),行为变体AD (bvAD) 和皮层底综合征 (CBS-AD).
主要方法:
- 利用了来自14个国际地点的320名非典型阿尔茨海默病患者的横截面和纵向tau-PET数据.
- 纳入了来自93名非典型阿尔茨海默病患者的区域性死后染.
- 采用高斯混合模型进行标记器协调和线性回归来评估功能连接与病理的关联.
主要成果:
- -PET的中心与临床变异保持一致,在PCA-AD中显示视觉网络模式,在lvPPA-AD中显示语言网络模式.
- 更强的功能连接与并发的tau-PET水平和积累率相关,由死后数据证实.
- -PET中心的功能连接性概况预测了-PET进展模式.
结论:
- 传播发生在源自本地中心的功能连接上,跨越所有AD临床变体.
- 研究结果支持这样一个假设:大脑网络连接指导在阿尔茨海默病中传播.
- 这种理解可能会推进个性化医学和阿尔茨海默病的临床试验终点.
相关概念视频
Alzheimer's Disease: Overview
668
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
668
Alzheimer's Disease: Treatment
261
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
261


